Lastly, to evaluate tumor CXCR2 signaling, we analyzed osteoclast homing at the tumor-bone interface in the sections of mice injected with Cl66-Control or Cl66-shCXCR2 cells. This evidence concerns the gene CXCR2 and neoplasm.